Similar articles

• Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor.

  Peri A, Bonaccorsi L, Muratori M, Luconi M, Baldi E, Granchi S, Pesciullesi A, Mini E, Cioppi F, Forti G, Serio M, Miele L, Maggi M. Peri A, et al. Int J Cancer. 2000 Nov 15;88(4):525-34. doi: 10.1002/1097-0215(20001115)88:4<525::aid-ijc3>3.0.co;2-z. Int J Cancer. 2000. PMID: 11058867
• Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A.

  Maggi M, Bonaccorsi L, Finetti G, Carloni V, Muratori M, Laffi G, Forti G, Serio M, Baldi E. Maggi M, et al. Cancer Res. 1994 Sep 1;54(17):4777-84. Cancer Res. 1994. PMID: 7520361
• Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells.

  Bonaccorsi L, Luconi M, Maggi M, Muratori M, Forti G, Serio M, Baldi E. Bonaccorsi L, et al. Biochim Biophys Acta. 1997 Feb 4;1355(2):155-66. doi: 10.1016/s0167-4889(96)00125-5. Biochim Biophys Acta. 1997. PMID: 9042336
• Platelet-activating factor in human endometrium.

  Baldi E, Bonaccorsi L, Finetti G, Luconi M, Muratori M, Susini T, Forti G, Serio M, Maggi M. Baldi E, et al. J Steroid Biochem Mol Biol. 1994 Jun;49(4-6):359-63. doi: 10.1016/0960-0760(94)90280-1. J Steroid Biochem Mol Biol. 1994. PMID: 8043501 Review.
• PAF, a putative mediator of oral inflammation.

  McManus LM, Pinckard RN. McManus LM, et al. Crit Rev Oral Biol Med. 2000;11(2):240-58. doi: 10.1177/10454411000110020701. Crit Rev Oral Biol Med. 2000. PMID: 12002818 Review.